Entera Bio Ltd. logo

Entera Bio Ltd.

NASDAQ:ENTX

Overview | Financials
Company Name Entera Bio Ltd.
Symbol ENTX
Currency USD
Price 2.39
Market Cap 85,526,867
Dividend Yield 0%
52-week-range 0.52 - 3.35
Industry Biotechnology
Sector Healthcare
CEO Ms. Miranda J. Toledano M.B.A.
Website https://www.enterabio.com

An error occurred while fetching data.

About Entera Bio Ltd.

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II

Related Stocks

Seelos Therapeutics, Inc. logo

Seelos Therapeutics, Inc.

SEEL

1.63 USD

Dyadic International, Inc. logo

Dyadic International, Inc.

DYAI

1.669 USD

Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc.

ACHV

5.15 USD

Lantern Pharma Inc. logo

Lantern Pharma Inc.

LTRN

6.28 USD

Oncolytics Biotech Inc. logo

Oncolytics Biotech Inc.

ONCY

1.11 USD

BioVie Inc. logo

BioVie Inc.

BIVI

0.484 USD

CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

CASI

3.09 USD

Qilian International Holding Group Limited logo

Qilian International Holding Group Limited

QLI

0.72 USD

Financials

Numbers are in millions USD

Numbers are in millions USD